Stockscreener 앱 받기
97.20
0.55%
-0.3684
전일 마감가:
$97.57
열려 있는:
$97.56
하루 거래량:
410.98K
Relative Volume:
0.27
시가총액:
$11.03B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
41.36
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
-2.88%
1개월 성능:
-15.41%
6개월 성능:
+6.36%
1년 성능:
-15.71%
1일 변동 폭
$95.24
$97.56
1주일 범위
$95.24
$101.37
52주 변동 폭
$81.36
$120.39
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
97.31 | 11.06B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
516.87 | 192.99B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
208.79 | 148.11B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
658.07 | 52.49B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.22 | 35.28B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
317.48 | 31.33B | 3.17B | 642.63M | 516.49M | 10.77 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Revvity’s AI Push Brings Innovation Potential but Heightened Operational, Legal, and Reputational Risks - TipRanks
Insider Sell: Michelle Mcmurry-heath Sells Shares of Revvity Inc (RVTY) - GuruFocus
Decoding Revvity Inc (RVTY): A Strategic SWOT Insight - GuruFocus
How Investors May Respond To Revvity (RVTY) Strong Q4 Beat And Upbeat 2026 Outlook - Yahoo Finance
Revvity : Annual Report for Fiscal Year Ending 12/28, 2025 (Form 10-K) - marketscreener.com
Bond Watch: Is Revvity Inc showing insider buyingJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - baoquankhu1.vn
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - The Globe and Mail
Do Wall Street Analysts Like Revvity Stock? - inkl
Can Revvity Inc. stock hit record highs againExit Point & Risk Controlled Daily Plans - mfd.ru
King Luther Capital Management Corp Has $10.45 Million Stake in Revvity Inc. $RVTY - MarketBeat
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - MSN
Revvity tackles hidden TB threat with early testing strategy - Traders Union
Bretton Fund exits UNP and RVTY - MSN
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of “Hold” by Analysts - Defense World
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today - MSN
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - MSN
How To YieldBoost Revvity To 22.5% Using Options - Nasdaq
First National Bank of Omaha Buys New Position in Revvity Inc. $RVTY - MarketBeat
Revvity to Present at Upcoming Investor Conferences - pharmiweb.com
A major biomanufacturer is cutting over 100 jobs in Mass. - MSN
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Pioneer With 24.51% Upside Potential - DirectorsTalk Interviews
Discipline and Rules-Based Execution in RVTY Response - Stock Traders Daily
What’s the beta of Revvity Inc. stockJuly 2025 Setups & Technical Pattern Alert System - mfd.ru
Can Revvity Inc. stock double in the next yearMarket Trend Summary & Verified Technical Signals - mfd.ru
Revvity Expands Drug Discovery Tools As Investors Weigh Growth And Valuation - Sahm
Here's Why Revvity (RVTY) is a Strong Momentum Stock - Eastern Progress
With Revvity, Inc. (NYSE:RVTY) It Looks Like You'll Get What You Pay For - 富途牛牛
Will Revvity Inc. stock see insider buyingSwing Trade & Capital Efficiency Focused Ideas - mfd.ru
New York Life Investment Management LLC Acquires 11,583 Shares of Revvity Inc. $RVTY - MarketBeat
A | Is Revvity, Inc. showing insider buyingJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - mfd.ru
What insider trading reveals about Revvity Inc. stockQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - mfd.ru
Revvity Unveils SLAS2026 Platforms As Valuation Gap Attracts Attention - Sahm
Can Revvity Inc. outperform in the next rallyJuly 2025 Gainers & Reliable Entry Point Trade Alerts - mfd.ru
Revvity boosts momentum at SLAS2026 with full session lineup - Traders Union
Optical Preclinical Imaging Market size to hit $982.8 Million - openPR.com
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside - Sahm
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization - GlobeNewswire Inc.
Revvity showcases industry insights at SLAS2026 opening - Traders Union
Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Winners Losers: Can Revvity Inc outperform in the next rally2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Diamond Hill Capital Management Inc. Acquires New Holdings in Revvity Inc. $RVTY - MarketBeat
Downgrade Watch: Is Revvity Inc showing insider buyingInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Nigeria
Revvity delivers Q4 beat as earnings and revenue top forecasts - MSN
Assessing Revvity (RVTY) Valuation After New SLAS2026 Lab Automation Launches - Sahm
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity Inc (RVTY) Shares Gap Down to $100.55 on Feb 5 - GuruFocus
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - ChartMill
Truist Financial Corp Decreases Stake in Revvity Inc. $RVTY - MarketBeat
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
0.64%
자본화:
|
볼륨(24시간):